Thermo Fisher Scientific Inc. develops, makes and sells a range of products. The company has market cap of $59.45 billion. The Firm provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It has a 29.89 P/E ratio. It operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Ur-Energy Inc. (USA) (URG) formed wedge down with $0.63 target or 6.00% below today’s $0.67 share price. Ur-Energy Inc. (USA) (URG) has $93.35M valuation. About 99,550 shares traded. Ur-Energy Inc. (USA) (NYSEMKT:URG) has risen 25.45% since September 7, 2016 and is uptrending. It has outperformed by 18.19% the S&P500.
About 418,948 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 1.30% since September 7, 2016 and is uptrending. It has underperformed by 5.96% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 6 sales for $7.75 million activity.
Cryder Capital Partners Llp holds 12.12% of its portfolio in Thermo Fisher Scientific Inc. for 192,286 shares. Veritas Investment Management Llp owns 366,722 shares or 9.15% of their US portfolio. Moreover, Consulta Ltd has 7.19% invested in the company for 400,000 shares. The United Kingdom-based Caledonia Investments Plc has invested 7.05% in the stock. Veritas Investment Management (Uk) Ltd, a United Kingdom-based fund reported 107,495 shares.
Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 27. They expect $2.03 earnings per share, up 12.78% or $0.23 from last year’s $1.8 per share. TMO’s profit will be $792.04M for 18.76 P/E if the $2.03 EPS becomes a reality. After $2.41 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -15.77% negative EPS growth.
Ratings analysis reveals 86% of Thermo Fisher Scientific’s analysts are positive. Out of 14 Wall Street analysts rating Thermo Fisher Scientific, 12 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $140 while the high is $180. The stock’s average target of $157.79 is 3.56% above today’s ($152.37) share price. TMO was included in 29 notes of analysts from July 24, 2015. The rating was initiated by JP Morgan with “Overweight” on Thursday, September 22. The firm earned “Buy” rating on Monday, January 11 by Stifel Nicolaus. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Tuesday, May 3 by Mizuho. The rating was maintained by Barclays Capital with “Overweight” on Tuesday, July 19. As per Friday, April 29, the company rating was downgraded by Jefferies. The stock has “Buy” rating by Mizuho on Friday, May 27. The firm has “Buy” rating given on Tuesday, October 6 by Argus Research. On Thursday, November 10 the stock rating was reinitiated by Leerink Swann with “Outperform”. Cleveland downgraded the stock to “Neutral” rating in Friday, September 9 report. The rating was maintained by Mizuho with “Buy” on Thursday, July 23.
